EPO and cancer: The network- and pathway-based analysis indicate that EPO and SPO- specific constituents converge on a shared set of multifunctional genes enriched in inflammatory, oxidative-stress, and cancer-associated signaling pathways, with NOS2 emerging as a common putative core target.